TABLE 1.
Stage 1 |
Stage 2 |
|||
Characteristic | Nonedematous | Edematous | Nonedematous | Edematous |
n | 10 | 9 | 10 | 9 |
Age (mo) | 13.0 ± 2.1 | 8.7 ± 1.3 | 13.5 ± 2.12 | 9.4 ± 1.32 |
Weight (kg)3 | 6.0 ± 0.4 | 4.7 ± 0.44 | 6.7 ± 0.52 | 5.2 ± 0.324 |
Length (cm) | 67.7 ± 2.2 | 59.2 ± 1.44 | 68.4 ± 2.22 | 59.4 ± 1.34 |
Weight for age3 (% of expected) | 61.7 ± 3.4 | 55.9 ± 4.3 | 67.7 ± 3.72 | 59.4 ± 3.624 |
Weight for length3 (% of expected) | 77.6 ± 1.7 | 86.3 ± 2.84 | 84.8 ± 1.92 | 93.5 ± 1.62 |
Albumin (g/L) | 37.4 ± 2.0 | 20.1 ± 2.44 | 42.9 ± 1.42 | 33.0 ± 3.24 |
Hemoglobin (g/dL) | 9.5 ± 0.4 | 7.7 ± 0.44 | 9.5 ± 0.3 | 8.6 ± 0.324 |
All values are means ± SEMs. Stage 1: ∼4 d after admission; stage 2: ∼20 d after admission when the children had replaced 50% of their weight deficit.
Significantly different from the corresponding clinical phase, P < 0.05 (paired t test).
Weight was adjusted for edema which was estimated as the difference between body weight on the day of the stage 1 experiment and the lowest post experiment weight measured. All children were edema free at stage 2.
Significantly different from nonedematous patients in the same clinical phase, P < 0.05 (unpaired t test).